IL-18-armored CAR T Drives Remissions in Relapsed B-Cell Leukemia
Published: | Updated:
An expert discusses IL-18-armored CAR T cells for adults with relapsed B-cell leukemia, showing complete remissions with manageable side effects.
Dr. Matthew P. Connor
Advertisement
Articles by Dr. Matthew P. Connor
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Revtorpyk for Advanced HR-Positive, HER2-Negative Breast Cancer
2
GLP-1s: Weight Loss and Survival in Breast Cancer Recovery
3
FDA Grants Traditional Approval to Retevmo for RET Fusion-Positive Solid Tumors
4
Why "You'll Be Fine" Isn't Always Comforting After Cancer
5